25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ANGO (Angiodynamics) Stock Analysis
Buy, Hold or Sell?

Let's analyze Angiodynamics together

I guess you are interested in AngioDynamics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Angiodynamicsโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Angiodynamicsโ€™s Price Targets

I'm going to help you getting a better view of AngioDynamics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about AngioDynamics Inc

I send you an email if I find something interesting about AngioDynamics Inc.

1. Quick Overview

1.1. Quick analysis of Angiodynamics (30 sec.)










1.2. What can you expect buying and holding a share of Angiodynamics? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.55
Expected worth in 1 year
$0.28
How sure are you?
42.5%

+ What do you gain per year?

Total Gains per Share
$-4.26
Return On Investment
-44.5%

For what price can you sell your share?

Current Price per Share
$9.58
Expected price per share
$8.27 - $12.11
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Angiodynamics (5 min.)




Live pricePrice per Share (EOD)
$9.58
Intrinsic Value Per Share
$-12.07 - $-5.28
Total Value Per Share
$-7.52 - $-0.73

2.2. Growth of Angiodynamics (5 min.)




Is Angiodynamics growing?

Current yearPrevious yearGrowGrow %
How rich?$185.8m$402.4m-$203.7m-102.5%

How much money is Angiodynamics making?

Current yearPrevious yearGrowGrow %
Making money-$45.8m-$1.5m-$44.2m-96.6%
Net Profit Margin-61.7%-0.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Angiodynamics (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#85 / 159

Most Revenue
#84 / 159

Most Profit
#152 / 159

Most Efficient
#135 / 159
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Angiodynamics?

Welcome investor! Angiodynamics's management wants to use your money to grow the business. In return you get a share of Angiodynamics.

First you should know what it really means to hold a share of Angiodynamics. And how you can make/lose money.

Speculation

The Price per Share of Angiodynamics is $9.58. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Angiodynamics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Angiodynamics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.55. Based on the TTM, the Book Value Change Per Share is $-1.07 per quarter. Based on the YOY, the Book Value Change Per Share is $0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Angiodynamics.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.11-1.1%-1.13-11.8%0.515.4%-0.42-4.4%-0.49-5.1%-0.24-2.5%
Usd Book Value Change Per Share-0.01-0.1%-1.07-11.1%0.030.3%-0.50-5.2%-0.50-5.3%-0.22-2.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.1%-1.07-11.1%0.030.3%-0.50-5.2%-0.50-5.3%-0.22-2.3%
Usd Price Per Share9.29-7.10-8.01-10.55-13.98-15.34-
Price to Earnings Ratio-21.53--7.82-0.53--9.61--18.35--129.27-
Price-to-Total Gains Ratio-650.89--146.00--7.74--93.98--102.38--34.77-
Price to Book Ratio2.04-1.47-0.81-1.37-1.50-1.38-
Price-to-Total Gains Ratio-650.89--146.00--7.74--93.98--102.38--34.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.58
Number of shares104
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.07-0.50
Usd Total Gains Per Share-1.07-0.50
Gains per Quarter (104 shares)-110.88-52.33
Gains per Year (104 shares)-443.54-209.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-444-4540-209-219
20-887-8980-419-428
30-1331-13420-628-637
40-1774-17860-837-846
50-2218-22300-1047-1055
60-2661-26740-1256-1264
70-3105-31180-1465-1473
80-3548-35620-1674-1682
90-3992-40060-1884-1891
100-4435-44500-2093-2100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.05.00.00.0%2.010.00.016.7%2.019.00.09.5%12.028.00.030.0%51.038.00.057.3%
Book Value Change Per Share0.05.00.00.0%1.011.00.08.3%2.019.00.09.5%17.023.00.042.5%63.025.01.070.8%
Dividend per Share0.00.05.00.0%0.00.012.00.0%0.00.021.00.0%0.00.040.00.0%0.00.089.00.0%
Total Gains per Share0.05.00.00.0%1.011.00.08.3%2.019.00.09.5%17.023.00.042.5%63.025.01.070.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of AngioDynamics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.014-1.066+7370%0.029-149%-0.503+3422%-0.503+3425%-0.221+1449%
Book Value Per Share--4.5504.880-7%9.911-54%7.885-42%9.394-52%11.331-60%
Current Ratio--2.2092.170+2%2.461-10%2.233-1%2.482-11%2.595-15%
Debt To Asset Ratio--0.3490.344+1%0.207+69%0.280+24%0.252+38%0.253+38%
Debt To Equity Ratio--0.5360.524+2%0.269+99%0.401+34%0.346+55%0.346+55%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--324739370.000246861362.000+32%273199713.333+19%360389720.833-10%493281199.762-34%519609846.875-38%
Eps---0.108-1.128+946%0.515-121%-0.418+287%-0.490+355%-0.237+120%
Ev To Ebitda Ratio---246.762-52.542-79%-740.172+200%-196.609-20%-114.771-53%-37.481-85%
Ev To Sales Ratio--1.1280.864+31%0.827+36%1.1320%1.624-31%1.621-30%
Free Cash Flow Per Share---0.366-0.244-33%-0.058-84%-0.140-62%-0.110-70%0.046-894%
Free Cash Flow To Equity Per Share---0.191-0.238+24%-0.556+191%-0.209+9%-0.114-41%-0.070-63%
Gross Profit Margin--6.7873.427+98%1.502+352%3.142+116%3.646+86%16.202-58%
Intrinsic Value_10Y_max---5.277----------
Intrinsic Value_10Y_min---12.068----------
Intrinsic Value_1Y_max--0.081----------
Intrinsic Value_1Y_min---0.675----------
Intrinsic Value_3Y_max---0.221----------
Intrinsic Value_3Y_min---2.502----------
Intrinsic Value_5Y_max---1.083----------
Intrinsic Value_5Y_min---4.836----------
Market Cap389015060.000+2%379524370.000289109562.000+31%325126713.333+17%428804804.167-11%567827961.667-33%623209321.875-39%
Net Profit Margin---0.061-0.617+908%-0.007-89%-0.296+384%-0.333+444%-0.166+171%
Operating Margin---0.092-0.137+48%-0.146+58%-0.124+34%-0.238+158%-0.125+35%
Operating Ratio--1.0561.104-4%1.078-2%1.084-3%1.076-2%1.012+4%
Pb Ratio2.106+3%2.0421.474+39%0.813+151%1.367+49%1.499+36%1.382+48%
Pe Ratio-22.202-3%-21.530-7.823-64%0.529-4169%-9.613-55%-18.348-15%-129.266+500%
Price Per Share9.580+3%9.2907.096+31%8.007+16%10.550-12%13.978-34%15.344-39%
Price To Free Cash Flow Ratio-6.542-3%-6.344-16.361+158%5.820-209%12.767-150%27.879-123%23.656-127%
Price To Total Gains Ratio-671.210-3%-650.891-146.000-78%-7.745-99%-93.977-86%-102.383-84%-34.769-95%
Quick Ratio--1.2021.267-5%1.491-19%1.280-6%1.409-15%1.534-22%
Return On Assets---0.015-0.143+828%-0.002-88%-0.066+326%-0.055+255%-0.028+80%
Return On Equity---0.024-0.214+803%-0.007-69%-0.099+316%-0.079+232%-0.040+69%
Total Gains Per Share---0.014-1.066+7370%0.029-149%-0.503+3422%-0.503+3425%-0.221+1449%
Usd Book Value--185870000.000198700800.000-6%402442000.000-54%320414416.667-42%381577142.857-51%460169375.000-60%
Usd Book Value Change Per Share---0.014-1.066+7370%0.029-149%-0.503+3422%-0.503+3425%-0.221+1449%
Usd Book Value Per Share--4.5504.880-7%9.911-54%7.885-42%9.394-52%11.331-60%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--324739370.000246861362.000+32%273199713.333+19%360389720.833-10%493281199.762-34%519609846.875-38%
Usd Eps---0.108-1.128+946%0.515-121%-0.418+287%-0.490+355%-0.237+120%
Usd Free Cash Flow---14957000.000-9917800.000-34%-2360000.000-84%-5693333.333-62%-4482285.714-70%1869625.000-900%
Usd Free Cash Flow Per Share---0.366-0.244-33%-0.058-84%-0.140-62%-0.110-70%0.046-894%
Usd Free Cash Flow To Equity Per Share---0.191-0.238+24%-0.556+191%-0.209+9%-0.114-41%-0.070-63%
Usd Market Cap389015060.000+2%379524370.000289109562.000+31%325126713.333+17%428804804.167-11%567827961.667-33%623209321.875-39%
Usd Price Per Share9.580+3%9.2907.096+31%8.007+16%10.550-12%13.978-34%15.344-39%
Usd Profit---4407000.000-45825600.000+940%-1543666.667-65%-22583333.333+412%-23076428.571+424%-11229950.000+155%
Usd Revenue--72004000.00071700400.000+0%82942000.000-13%78500333.333-8%75730809.524-5%80609775.000-11%
Usd Total Gains Per Share---0.014-1.066+7370%0.029-149%-0.503+3422%-0.503+3425%-0.221+1449%
 EOD+5 -3MRQTTM+24 -14YOY+14 -243Y+18 -205Y+16 -2210Y+13 -25

3.3 Fundamental Score

Let's check the fundamental score of AngioDynamics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-22.202
Price to Book Ratio (EOD)Between0-12.106
Net Profit Margin (MRQ)Greater than0-0.061
Operating Margin (MRQ)Greater than0-0.092
Quick Ratio (MRQ)Greater than11.202
Current Ratio (MRQ)Greater than12.209
Debt to Asset Ratio (MRQ)Less than10.349
Debt to Equity Ratio (MRQ)Less than10.536
Return on Equity (MRQ)Greater than0.15-0.024
Return on Assets (MRQ)Greater than0.05-0.015
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of AngioDynamics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.718
Ma 20Greater thanMa 5010.316
Ma 50Greater thanMa 1009.855
Ma 100Greater thanMa 2009.776
OpenGreater thanClose9.380
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Fundamental data was last updated by Penke on 2025-06-18 23:19:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Angiodynamics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Angiodynamics to theย Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -6.1%ย means thatย $-0.06 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AngioDynamics Inc:

  • The MRQ is -6.1%. The company is making a loss. -1
  • The TTM is -61.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-6.1%TTM-61.7%+55.6%
TTM-61.7%YOY-0.7%-61.0%
TTM-61.7%5Y-33.3%-28.4%
5Y-33.3%10Y-16.6%-16.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.1%4.8%-10.9%
TTM-61.7%4.7%-66.4%
YOY-0.7%6.3%-7.0%
3Y-29.6%6.4%-36.0%
5Y-33.3%6.1%-39.4%
10Y-16.6%6.6%-23.2%
4.3.1.2. Return on Assets

Shows howย efficientย Angiodynamics is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Angiodynamics to theย Medical Instruments & Supplies industry mean.
  • -1.5% Return on Assets means thatย Angiodynamics generatedย $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AngioDynamics Inc:

  • The MRQ is -1.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.5%TTM-14.3%+12.8%
TTM-14.3%YOY-0.2%-14.1%
TTM-14.3%5Y-5.5%-8.8%
5Y-5.5%10Y-2.8%-2.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.5%1.0%-2.5%
TTM-14.3%1.0%-15.3%
YOY-0.2%1.0%-1.2%
3Y-6.6%1.1%-7.7%
5Y-5.5%1.5%-7.0%
10Y-2.8%1.5%-4.3%
4.3.1.3. Return on Equity

Shows how efficient Angiodynamics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Angiodynamics to theย Medical Instruments & Supplies industry mean.
  • -2.4% Return on Equity means Angiodynamics generated $-0.02ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AngioDynamics Inc:

  • The MRQ is -2.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.4%TTM-21.4%+19.0%
TTM-21.4%YOY-0.7%-20.7%
TTM-21.4%5Y-7.9%-13.5%
5Y-7.9%10Y-4.0%-3.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.4%2.2%-4.6%
TTM-21.4%1.9%-23.3%
YOY-0.7%1.8%-2.5%
3Y-9.9%2.1%-12.0%
5Y-7.9%3.1%-11.0%
10Y-4.0%2.9%-6.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of AngioDynamics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Angiodynamics is operatingย .

  • Measures how much profit Angiodynamics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Angiodynamics to theย Medical Instruments & Supplies industry mean.
  • An Operating Margin of -9.2%ย means the company generated $-0.09 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AngioDynamics Inc:

  • The MRQ is -9.2%. The company is operating very inefficient. -2
  • The TTM is -13.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-9.2%TTM-13.7%+4.4%
TTM-13.7%YOY-14.6%+1.0%
TTM-13.7%5Y-23.8%+10.2%
5Y-23.8%10Y-12.5%-11.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.2%7.9%-17.1%
TTM-13.7%5.8%-19.5%
YOY-14.6%5.9%-20.5%
3Y-12.4%6.6%-19.0%
5Y-23.8%8.7%-32.5%
10Y-12.5%9.0%-21.5%
4.3.2.2. Operating Ratio

Measures how efficient Angiodynamics is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.06 means that the operating costs are $1.06 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AngioDynamics Inc:

  • The MRQ is 1.056. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.104. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.056TTM1.104-0.048
TTM1.104YOY1.078+0.026
TTM1.1045Y1.076+0.028
5Y1.07610Y1.012+0.064
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0561.201-0.145
TTM1.1041.131-0.027
YOY1.0781.036+0.042
3Y1.0841.0840.000
5Y1.0761.054+0.022
10Y1.0121.018-0.006
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of AngioDynamics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Angiodynamics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.21ย means the company has $2.21 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AngioDynamics Inc:

  • The MRQ is 2.209. The company is able to pay all its short-term debts. +1
  • The TTM is 2.170. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.209TTM2.170+0.039
TTM2.170YOY2.461-0.290
TTM2.1705Y2.482-0.312
5Y2.48210Y2.595-0.113
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2092.092+0.117
TTM2.1702.062+0.108
YOY2.4612.318+0.143
3Y2.2332.405-0.172
5Y2.4822.641-0.159
10Y2.5952.594+0.001
4.4.3.2. Quick Ratio

Measures if Angiodynamics is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Angiodynamics to theย Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.20ย means the company can pay off $1.20 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AngioDynamics Inc:

  • The MRQ is 1.202. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.267. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.202TTM1.267-0.065
TTM1.267YOY1.491-0.224
TTM1.2675Y1.409-0.142
5Y1.40910Y1.534-0.125
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2020.839+0.363
TTM1.2670.963+0.304
YOY1.4911.090+0.401
3Y1.2801.201+0.079
5Y1.4091.425-0.016
10Y1.5341.556-0.022
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of AngioDynamics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Angiodynamicsย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Angiodynamics to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.35ย means that Angiodynamics assets areย financed with 34.9% credit (debt) and the remaining percentage (100% - 34.9%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of AngioDynamics Inc:

  • The MRQ is 0.349. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.344. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.349TTM0.344+0.005
TTM0.344YOY0.207+0.137
TTM0.3445Y0.252+0.092
5Y0.25210Y0.253-0.001
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3490.395-0.046
TTM0.3440.384-0.040
YOY0.2070.357-0.150
3Y0.2800.350-0.070
5Y0.2520.357-0.105
10Y0.2530.373-0.120
4.5.4.2. Debt to Equity Ratio

Measures ifย Angiodynamics is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Angiodynamics to theย Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 53.6% means that company has $0.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AngioDynamics Inc:

  • The MRQ is 0.536. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.524. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.536TTM0.524+0.011
TTM0.524YOY0.269+0.255
TTM0.5245Y0.346+0.178
5Y0.34610Y0.346+0.001
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5360.603-0.067
TTM0.5240.584-0.060
YOY0.2690.558-0.289
3Y0.4010.578-0.177
5Y0.3460.567-0.221
10Y0.3460.660-0.314
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Angiodynamics generates.

  • Above 15 is considered overpriced butย always compareย Angiodynamics to theย Medical Instruments & Supplies industry mean.
  • A PE ratio of -21.53 means the investor is paying $-21.53ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AngioDynamics Inc:

  • The EOD is -22.202. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.530. Based on the earnings, the company is expensive. -2
  • The TTM is -7.823. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.202MRQ-21.530-0.672
MRQ-21.530TTM-7.823-13.706
TTM-7.823YOY0.529-8.352
TTM-7.8235Y-18.348+10.525
5Y-18.34810Y-129.266+110.918
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-22.20215.581-37.783
MRQ-21.53014.611-36.141
TTM-7.82314.998-22.821
YOY0.52917.278-16.749
3Y-9.61318.333-27.946
5Y-18.34820.653-39.001
10Y-129.26621.679-150.945
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AngioDynamics Inc:

  • The EOD is -6.542. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.344. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -16.361. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.542MRQ-6.344-0.198
MRQ-6.344TTM-16.361+10.018
TTM-16.361YOY5.820-22.182
TTM-16.3615Y27.879-44.240
5Y27.87910Y23.656+4.223
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-6.5429.751-16.293
MRQ-6.3449.061-15.405
TTM-16.3619.766-26.127
YOY5.8209.084-3.264
3Y12.7674.244+8.523
5Y27.8793.685+24.194
10Y23.6560.783+22.873
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Angiodynamics is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 2.04 means the investor is paying $2.04ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of AngioDynamics Inc:

  • The EOD is 2.106. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.042. Based on the equity, the company is underpriced. +1
  • The TTM is 1.474. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.106MRQ2.042+0.064
MRQ2.042TTM1.474+0.568
TTM1.474YOY0.813+0.661
TTM1.4745Y1.499-0.025
5Y1.49910Y1.382+0.117
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD2.1062.539-0.433
MRQ2.0422.393-0.351
TTM1.4742.562-1.088
YOY0.8132.723-1.910
3Y1.3672.756-1.389
5Y1.4993.542-2.043
10Y1.3824.090-2.708
4.6.2. Total Gains per Share

2.4. Latest News of AngioDynamics Inc

Does AngioDynamics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from AngioDynamics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-18
11:30
Validea Kenneth Fisher Strategy Daily Upgrade Report - 6/18/2025Read
2025-06-09
17:35
Zacks Industry Outlook Penumbra, Integer and AngioDynamicsRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of AngioDynamics Inc.

4.8.1. Institutions holding AngioDynamics Inc

Institutions are holding 90.721% of the shares of AngioDynamics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc8.77710.00073596042-345588-8.7676
2025-03-31Systematic Financial Management LP6.09530.6682497289-23776-0.9431
2025-03-31Vanguard Group Inc6.08380.000424925631999448.7212
2025-03-31Armistice Capital, LLC5.1110.294720940001222000140.1376
2025-03-31Segall Bryant & Hamill3.37910.19921384439-30717-2.1706
2024-12-31Nuveen Asset Management, LLC3.16410.0034129636635307037.4294
2025-03-31Millennium Management LLC3.02550.00621239572-922996-42.6806
2025-03-31Dimensional Fund Advisors, Inc.2.84490.00271165569-323098-21.7038
2025-03-31Nuveen, LLC2.80810.0033115051811505180
2025-03-31Royce & Associates, LP2.50820.10461027630-91755-8.1969
2025-03-31Geode Capital Management, LLC2.40830.0007986720124181.2746
2025-03-31Divisadero Street Capital Management, LP2.34330.907396006544543086.5526
2024-12-31UBS Group AG2.30060.00169425659165413521.9067
2025-03-31Point72 Asset Management, L.P.2.26660.01999286579286570
2025-03-31Renaissance Technologies Corp2.18670.0127895929-17100-1.8729
2025-03-31State Street Corp2.04920.000383955860350.724
2025-03-31Morgan Stanley - Brokerage Accounts1.7170.000570348517632833.4489
2025-03-31Bastion Asset Management Inc.1.59833.55566548266548260
2025-03-31Arrowstreet Capital Limited Partnership1.31830.004154010218755853.2013
2025-03-31Pier Capital, LLC1.20570.77724939914939910
Total 63.19116.563125889886+4992286+19.3%

4.9.2. Funds holding AngioDynamics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.95090.00071209027100800.8407
2025-05-31iShares Russell 2000 ETF2.37260.016197208100
2025-04-30CREF Stock R31.6840.0054689947179282.6678
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.57240.005964421312530.1949
2025-03-31Royce Small-Cap Opportunity Invmt1.32070.5199541095-51143-8.6355
2025-05-31FTGF RY US SmCp Opp A USD Dis(A)1.09080.5574446903-6506-1.4349
2025-04-30Nuveen Quant Small Cap Equity R61.08030.13364426008039022.1943
2025-03-31Fidelity Small Cap Index0.94620.01513876468730.2257
2025-05-31iShares Russell 2000 Value ETF0.85030.033134837900
2025-04-30Segall Bryant & Hamill Sm Cp Val Ins0.80180.814532849500
2025-03-31First Eagle US Small Cap Strategy0.80150.1944328388-37603-10.2743
2025-04-30First Eagle Small Cap Opportunity I0.69960.1813286645-41743-12.7115
2025-05-31SEB Nordamerikafond Smรฅbolag0.60981.15472498383780017.827
2025-04-30BlackRock Advantage Small Cap Core Instl0.60380.061424736800
2025-05-31State St Russell Sm/Mid Cpยฎ Indx SL Cl I0.58160.005923828200
2025-04-30Fidelity Extended Market Index0.55790.0059228569-9467-3.9771
2025-03-31Pier Capital Small Cap Growth Equity0.50130.75462054067415056.4927
2025-05-31Schwab US Small-Cap ETFโ„ข0.47770.0121195706-518-0.264
2025-04-30Vanguard Russell 2000 ETF0.47080.0152192874106575.8485
2025-03-31Kennedy Micro Cap0.44240.3587181262-970-0.5323
Total 20.41644.84598364724+85181+1.0%

5.3. Insider Transactions

Insiders are holding 5.596% of the shares of AngioDynamics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-01-16Warren Nighan JrSELL406012.31
2024-10-10Warren Nighan JrBUY1006.08
2024-10-08Stephen A TrowbridgeBUY17005.86
2024-10-07James C ClemmerBUY200006.03
2024-10-07Warren Nighan JrBUY7686.09
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-02-28. Currency in USD. All numbers in thousands.

Summary
Total Assets285,415
Total Liabilities99,545
Total Stockholder Equity185,870
 As reported
Total Liabilities 99,545
Total Stockholder Equity+ 185,870
Total Assets = 285,415

Assets

Total Assets285,415
Total Current Assets172,273
Long-term Assets113,142
Total Current Assets
Cash And Cash Equivalents 44,760
Net Receivables 48,968
Inventory 63,105
Other Current Assets 15,440
Total Current Assets  (as reported)172,273
Total Current Assets  (calculated)172,273
+/-0
Long-term Assets
Property Plant Equipment 32,530
Intangible Assets 70,931
Long-term Assets Other 9,681
Long-term Assets  (as reported)113,142
Long-term Assets  (calculated)113,142
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities77,971
Long-term Liabilities21,574
Total Stockholder Equity185,870
Total Current Liabilities
Short-term Debt 5,000
Short Long Term Debt 5,000
Accounts payable 30,265
Other Current Liabilities 41,747
Total Current Liabilities  (as reported)77,971
Total Current Liabilities  (calculated)82,012
+/- 4,041
Long-term Liabilities
Long-term Liabilities Other 17,371
Long-term Liabilities  (as reported)21,574
Long-term Liabilities  (calculated)17,371
+/- 4,203
Total Stockholder Equity
Common Stock385
Other Stockholders Equity 185,485
Total Stockholder Equity (as reported)185,870
Total Stockholder Equity (calculated)185,870
+/-0
Other
Capital Stock385
Cash and Short Term Investments 44,760
Common Stock Shares Outstanding 40,853
Liabilities and Stockholders Equity 285,415
Net Debt -39,760
Net Invested Capital 190,870
Net Working Capital 94,302
Short Long Term Debt Total 5,000



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-02-282024-11-302024-08-312024-05-312024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302012-08-312012-05-312012-02-292011-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302009-08-312009-05-312009-02-282008-11-302008-08-312008-05-312008-02-292007-11-302007-08-312007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312005-05-312005-02-282004-11-302004-08-312004-05-312004-02-292003-11-302003-05-312003-02-282002-05-31
> Total Assets 
20,647
0
27,056
28,542
29,072
49,726
48,630
50,372
53,835
59,672
61,335
64,238
70,227
137,000
141,758
149,114
377,280
383,281
385,040
392,820
396,939
408,747
395,970
392,951
400,579
408,703
409,280
407,633
412,295
423,925
420,351
425,983
433,399
437,546
439,608
443,590
446,607
725,077
717,992
778,947
796,471
791,882
801,153
795,490
792,174
800,157
797,295
799,330
783,136
773,623
771,789
760,371
753,513
728,063
726,711
712,170
704,318
707,961
700,341
697,806
698,429
705,472
693,871
783,960
777,795
836,438
690,364
724,879
731,961
595,512
583,759
588,521
582,245
561,438
555,763
554,103
543,178
552,751
557,652
558,207
542,849
532,637
493,949
499,623
324,842
317,671
293,628
291,550
285,415
285,415291,550293,628317,671324,842499,623493,949532,637542,849558,207557,652552,751543,178554,103555,763561,438582,245588,521583,759595,512731,961724,879690,364836,438777,795783,960693,871705,472698,429697,806700,341707,961704,318712,170726,711728,063753,513760,371771,789773,623783,136799,330797,295800,157792,174795,490801,153791,882796,471778,947717,992725,077446,607443,590439,608437,546433,399425,983420,351423,925412,295407,633409,280408,703400,579392,951395,970408,747396,939392,820385,040383,281377,280149,114141,758137,00070,22764,23861,33559,67253,83550,37248,63049,72629,07228,54227,056020,647
   > Total Current Assets 
0
0
18,525
0
19,736
40,375
39,203
40,871
44,452
49,707
51,036
50,748
56,097
122,156
121,998
123,716
121,219
127,861
126,659
134,428
140,625
141,882
125,435
124,123
134,617
148,598
152,684
151,627
158,351
171,360
169,782
177,446
186,567
194,430
199,866
205,836
211,049
159,278
160,221
151,463
146,440
141,573
145,234
141,573
140,131
152,236
154,802
163,446
157,292
155,813
160,025
151,558
149,401
146,254
152,282
147,802
145,051
153,914
150,722
152,495
156,569
168,032
120,885
142,957
142,740
315,292
166,357
131,976
129,046
152,913
142,238
149,704
145,657
140,879
131,321
132,185
127,686
143,345
151,371
158,830
152,574
163,542
175,475
185,468
196,907
193,253
172,594
175,360
172,273
172,273175,360172,594193,253196,907185,468175,475163,542152,574158,830151,371143,345127,686132,185131,321140,879145,657149,704142,238152,913129,046131,976166,357315,292142,740142,957120,885168,032156,569152,495150,722153,914145,051147,802152,282146,254149,401151,558160,025155,813157,292163,446154,802152,236140,131141,573145,234141,573146,440151,463160,221159,278211,049205,836199,866194,430186,567177,446169,782171,360158,351151,627152,684148,598134,617124,123125,435141,882140,625134,428126,659127,861121,219123,716121,998122,15656,09750,74851,03649,70744,45240,87139,20340,37519,736018,52500
       Cash And Cash Equivalents 
1,525
0
939
0
1,332
1,747
20,749
11,849
15,404
14,498
13,298
13,043
13,356
64,042
70,786
73,158
38,052
28,313
23,426
22,759
43,646
32,040
18,518
19,734
26,776
27,909
32,168
36,256
37,513
58,763
67,202
27,132
35,257
45,984
50,493
42,955
34,047
23,508
18,896
19,322
16,625
21,802
22,065
15,173
7,382
16,105
13,808
14,877
19,704
18,391
20,268
18,996
21,897
32,333
37,411
35,664
35,571
47,544
48,200
49,856
52,292
74,096
24,762
42,820
41,704
227,641
83,649
41,247
27,160
54,435
47,929
58,025
54,469
48,161
35,472
34,291
23,890
28,825
24,564
29,857
30,111
44,620
57,586
60,896
78,451
76,056
55,005
54,089
44,760
44,76054,08955,00576,05678,45160,89657,58644,62030,11129,85724,56428,82523,89034,29135,47248,16154,46958,02547,92954,43527,16041,24783,649227,64141,70442,82024,76274,09652,29249,85648,20047,54435,57135,66437,41132,33321,89718,99620,26818,39119,70414,87713,80816,1057,38215,17322,06521,80216,62519,32218,89623,50834,04742,95550,49345,98435,25727,13267,20258,76337,51336,25632,16827,90926,77619,73418,51832,04043,64622,75923,42628,31338,05273,15870,78664,04213,35613,04313,29814,49815,40411,84920,7491,7471,332093901,525
       Short-term Investments 
1,318
0
729
0
735
737
739
10,354
9,590
12,601
15,516
14,440
15,551
25,710
18,421
14,790
28,977
43,191
46,167
45,612
34,206
46,182
40,731
38,108
35,557
40,278
36,588
37,772
48,265
41,311
34,796
83,471
84,973
85,558
86,158
93,364
108,980
14,070
11,627
2,155
2,154
2,153
1,850
1,850
1,807
1,809
1,670
1,698
1,682
1,689
1,692
1,639
1,666
1,653
1,647
1,203
1,203
1,215
1,215
1,260
1,281
1,317
1,350
1,350
0
0
0
0
0
689
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000689000001,3501,3501,3171,2811,2601,2151,2151,2031,2031,6471,6531,6661,6391,6921,6891,6821,6981,6701,8091,8071,8501,8502,1532,1542,15511,62714,070108,98093,36486,15885,55884,97383,47134,79641,31148,26537,77236,58840,27835,55738,10840,73146,18234,20645,61246,16743,19128,97714,79018,42125,71015,55114,44015,51612,6019,59010,354739737735072901,318
       Net Receivables 
0
0
6,532
0
7,332
27,894
7,176
7,936
8,350
9,929
9,484
10,814
12,182
13,486
12,135
14,213
18,929
20,798
19,686
22,216
22,762
26,642
24,375
25,733
26,501
27,181
23,383
25,397
26,536
29,838
23,637
25,762
28,461
27,141
26,365
31,451
26,723
54,394
45,428
49,585
45,110
47,683
46,561
48,405
57,726
61,968
56,026
58,556
57,770
58,428
52,424
53,118
54,446
52,867
50,124
50,171
46,302
44,523
41,283
42,073
41,827
39,401
40,164
43,374
44,208
43,577
32,540
33,994
35,619
31,263
33,590
33,604
33,171
35,405
35,416
38,205
41,810
52,304
53,586
52,852
50,892
52,826
49,755
51,603
49,475
43,610
39,563
43,158
48,968
48,96843,15839,56343,61049,47551,60349,75552,82650,89252,85253,58652,30441,81038,20535,41635,40533,17133,60433,59031,26335,61933,99432,54043,57744,20843,37440,16439,40141,82742,07341,28344,52346,30250,17150,12452,86754,44653,11852,42458,42857,77058,55656,02661,96857,72648,40546,56147,68345,11049,58545,42854,39426,72331,45126,36527,14128,46125,76223,63729,83826,53625,39723,38327,18126,50125,73324,37526,64222,76222,21619,68620,79818,92914,21312,13513,48612,18210,8149,4849,9298,3507,9367,17627,8947,33206,53200
       Other Current Assets 
665
0
1,694
955
1,351
1,452
1,323
1,687
1,720
2,415
1,740
1,746
1,871
2,950
2,235
2,868
7,933
6,990
6,626
16,314
14,687
14,117
13,612
11,964
13,368
16,302
16,201
12,328
11,922
12,232
10,630
8,350
8,387
7,496
7,178
8,639
13,141
11,443
18,356
18,071
34,402
14,437
24,502
16,093
13,382
10,606
12,380
13,000
9,426
4,902
11,314
6,992
5,600
4,031
4,826
4,097
4,294
6,870
4,599
5,274
4,605
4,302
9,776
9,552
8,880
4,003
9,878
12,992
11,369
7,310
15,914
16,986
9,011
1,760
22,256
11,506
13,947
14,513
31,224
12,944
8,039
4,617
8,162
8,715
10,913
16,107
13,326
12,195
15,440
15,44012,19513,32616,10710,9138,7158,1624,6178,03912,94431,22414,51313,94711,50622,2561,7609,01116,98615,9147,31011,36912,9929,8784,0038,8809,5529,7764,3024,6055,2744,5996,8704,2944,0974,8264,0315,6006,99211,3144,9029,42613,00012,38010,60613,38216,09324,50214,43734,40218,07118,35611,44313,1418,6397,1787,4968,3878,35010,63012,23211,92212,32816,20116,30213,36811,96413,61214,11714,68716,3146,6266,9907,9332,8682,2352,9501,8711,7461,7402,4151,7201,6871,3231,4521,3519551,6940665
   > Long-term Assets 
0
0
8,531
0
9,336
9,351
9,427
9,501
9,383
9,965
10,299
13,490
14,130
14,844
19,760
25,398
256,061
255,420
258,381
258,392
256,314
266,865
270,535
268,828
265,962
260,105
256,596
256,006
253,944
252,565
250,569
248,537
246,832
243,116
239,742
237,754
235,558
565,799
557,771
627,484
650,031
650,309
655,919
653,917
652,043
647,921
642,493
635,884
625,844
617,810
611,764
608,813
604,112
581,809
574,429
564,368
559,267
554,047
549,619
545,311
541,860
537,440
572,986
641,003
635,055
521,146
524,007
592,903
602,915
442,599
441,521
438,817
436,588
420,559
424,442
421,918
415,492
409,406
406,281
399,377
390,275
369,095
318,474
314,155
127,935
124,418
121,034
116,190
113,142
113,142116,190121,034124,418127,935314,155318,474369,095390,275399,377406,281409,406415,492421,918424,442420,559436,588438,817441,521442,599602,915592,903524,007521,146635,055641,003572,986537,440541,860545,311549,619554,047559,267564,368574,429581,809604,112608,813611,764617,810625,844635,884642,493647,921652,043653,917655,919650,309650,031627,484557,771565,799235,558237,754239,742243,116246,832248,537250,569252,565253,944256,006256,596260,105265,962268,828270,535266,865256,314258,392258,381255,420256,06125,39819,76014,84414,13013,49010,2999,9659,3839,5019,4279,3519,33608,53100
       Property Plant Equipment 
2,730
0
6,261
6,875
7,161
7,343
7,450
7,558
7,773
8,528
8,895
9,712
10,355
10,802
10,612
10,842
14,369
16,832
18,882
19,242
19,919
21,163
22,253
22,715
22,600
22,183
22,327
22,600
23,293
24,193
24,092
24,102
23,714
23,804
23,485
23,196
23,148
55,915
57,525
58,547
61,187
62,650
63,748
66,390
66,478
67,208
66,844
67,553
58,295
54,560
52,799
51,153
49,693
48,284
47,230
47,116
46,180
45,234
44,353
43,767
43,058
42,461
42,163
41,945
41,207
24,258
25,334
27,508
28,182
28,312
29,427
29,628
29,827
37,073
41,133
43,090
43,594
45,005
46,189
45,957
45,559
44,384
43,356
42,557
40,894
41,470
34,377
32,977
32,530
32,53032,97734,37741,47040,89442,55743,35644,38445,55945,95746,18945,00543,59443,09041,13337,07329,82729,62829,42728,31228,18227,50825,33424,25841,20741,94542,16342,46143,05843,76744,35345,23446,18047,11647,23048,28449,69351,15352,79954,56058,29567,55366,84467,20866,47866,39063,74862,65061,18758,54757,52555,91523,14823,19623,48523,80423,71424,10224,09224,19323,29322,60022,32722,18322,60022,71522,25321,16319,91919,24218,88216,83214,36910,84210,61210,80210,3559,7128,8958,5287,7737,5587,4507,3437,1616,8756,26102,730
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
169,626
153,787
154,341
154,430
154,430
162,707
164,522
164,540
161,990
161,974
161,974
161,974
161,974
161,974
161,974
161,964
161,959
161,951
161,951
161,951
161,951
313,975
307,171
337,190
356,692
355,440
359,736
359,736
359,736
360,294
361,215
360,473
360,473
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
361,252
382,992
426,874
423,674
347,666
347,666
360,094
359,093
201,515
200,943
201,117
201,102
201,316
201,491
201,709
201,484
201,058
201,038
200,755
199,976
159,238
159,017
159,226
0
0
0
0
0
00000159,226159,017159,238199,976200,755201,038201,058201,484201,709201,491201,316201,102201,117200,943201,515359,093360,094347,666347,666423,674426,874382,992361,252361,252361,252361,252361,252361,252361,252361,252361,252361,252361,252361,252361,252360,473360,473361,215360,294359,736359,736359,736355,440356,692337,190307,171313,975161,951161,951161,951161,951161,959161,964161,974161,974161,974161,974161,974161,974161,990164,540164,522162,707154,430154,430154,341153,787169,6260000000000000000
       Intangible Assets 
1,157
0
1,036
975
945
964
934
901
870
839
808
3,127
3,095
3,565
8,534
8,457
50,795
49,148
48,655
48,026
47,203
71,311
72,759
70,548
70,065
67,770
65,491
63,033
60,738
58,352
56,093
53,948
53,770
48,037
45,705
43,691
41,530
143,568
143,538
212,303
219,238
214,848
216,355
212,195
207,970
205,256
201,745
197,362
186,547
181,806
177,399
172,511
168,080
167,577
162,342
154,439
150,078
145,675
141,583
137,437
134,512
130,310
144,194
168,706
166,564
145,387
141,655
196,325
201,956
197,136
194,318
190,559
186,216
168,977
168,893
165,000
159,105
152,380
147,976
141,943
134,011
111,144
106,671
103,891
81,570
77,383
75,774
73,110
70,931
70,93173,11075,77477,38381,570103,891106,671111,144134,011141,943147,976152,380159,105165,000168,893168,977186,216190,559194,318197,136201,956196,325141,655145,387166,564168,706144,194130,310134,512137,437141,583145,675150,078154,439162,342167,577168,080172,511177,399181,806186,547197,362201,745205,256207,970212,195216,355214,848219,238212,303143,538143,56841,53043,69145,70548,03753,77053,94856,09358,35260,73863,03365,49167,77070,06570,54872,75971,31147,20348,02648,65549,14850,7958,4578,5343,5653,0953,1278088398709019349649459751,03601,157
       Long-term Assets Other 
0
0
408
0
404
402
401
400
98
97
95
94
94
91
90
5,299
6,356
6,364
8,223
9,599
9,270
4,824
3,802
3,931
875
908
3,798
5,187
5,298
2,557
2,777
5,925
5,751
3,489
3,674
4,046
3,765
11,906
10,934
10,166
5,646
6,123
5,307
5,543
5,592
5,397
3,950
3,260
4,060
5,288
4,818
4,071
5,524
4,696
3,605
1,561
1,757
1,886
2,431
2,855
3,038
3,417
3,637
3,478
3,610
3,835
9,352
8,976
13,684
15,636
16,833
17,513
19,443
-6,762
12,925
12,119
11,309
-5,074
-4,037
-3,568
-2,761
54,329
9,430
8,481
5,471
5,565
6,257
10,103
9,681
9,68110,1036,2575,5655,4718,4819,43054,329-2,761-3,568-4,037-5,07411,30912,11912,925-6,76219,44317,51316,83315,63613,6848,9769,3523,8353,6103,4783,6373,4173,0382,8552,4311,8861,7571,5613,6054,6965,5244,0714,8185,2884,0603,2603,9505,3975,5925,5435,3076,1235,64610,16610,93411,9063,7654,0463,6743,4895,7515,9252,7772,5575,2985,1873,7989088753,9313,8024,8249,2709,5998,2236,3646,3565,29990919494959798400401402404040800
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,927
4,870
5,164
39,198
38,603
9,278
7,268
11,007
10,227
9,507
11,721
10,403
9,236
7,236
16,469
14,904
15,496
19,826
19,563
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000019,56319,82615,49614,90416,4697,2369,23610,40311,7219,50710,22711,0077,2689,27838,60339,1985,1644,8704,9270000000000000000000000000000000000
> Total Liabilities 
20,942
0
25,568
25,586
25,352
12,494
7,897
8,513
8,598
10,562
9,317
9,950
12,893
13,562
14,755
17,845
46,014
47,323
44,672
46,870
43,389
53,034
36,023
29,414
32,694
36,509
33,251
26,894
25,385
32,576
24,916
26,531
27,825
31,798
30,307
32,745
35,244
201,685
193,483
252,259
269,114
265,052
272,708
265,761
254,485
262,264
256,969
255,760
239,380
228,601
224,666
212,732
202,768
221,036
213,994
188,821
172,568
190,934
182,457
176,586
160,101
162,877
148,982
234,397
223,716
221,623
76,291
111,069
121,486
139,640
128,705
134,178
127,309
121,981
119,813
121,735
113,486
128,262
143,611
150,249
145,194
154,341
66,145
98,397
106,144
112,085
97,046
104,782
99,545
99,545104,78297,046112,085106,14498,39766,145154,341145,194150,249143,611128,262113,486121,735119,813121,981127,309134,178128,705139,640121,486111,06976,291221,623223,716234,397148,982162,877160,101176,586182,457190,934172,568188,821213,994221,036202,768212,732224,666228,601239,380255,760256,969262,264254,485265,761272,708265,052269,114252,259193,483201,68535,24432,74530,30731,79827,82526,53124,91632,57625,38526,89433,25136,50932,69429,41436,02353,03443,38946,87044,67247,32346,01417,84514,75513,56212,8939,9509,31710,5628,5988,5137,89712,49425,35225,58625,568020,942
   > Total Current Liabilities 
5,777
0
6,165
6,253
6,064
9,394
4,837
5,493
5,618
7,627
6,427
7,105
10,093
10,807
8,545
11,680
15,714
20,418
37,262
39,625
36,229
41,334
24,345
22,484
25,884
29,699
26,506
20,214
18,770
26,026
18,431
20,121
21,480
25,523
24,107
26,620
29,194
59,185
51,379
60,385
66,830
63,735
74,363
69,079
63,380
72,244
64,246
57,937
59,687
61,157
60,651
60,104
61,579
67,096
65,431
50,752
50,641
69,516
64,323
59,660
54,403
57,301
45,789
49,702
53,295
73,302
47,172
57,005
48,712
51,534
39,846
45,812
50,256
57,584
52,097
54,475
49,368
74,324
66,390
73,567
69,632
83,825
57,452
78,037
85,874
91,155
76,699
88,595
77,971
77,97188,59576,69991,15585,87478,03757,45283,82569,63273,56766,39074,32449,36854,47552,09757,58450,25645,81239,84651,53448,71257,00547,17273,30253,29549,70245,78957,30154,40359,66064,32369,51650,64150,75265,43167,09661,57960,10460,65161,15759,68757,93764,24672,24463,38069,07974,36363,73566,83060,38551,37959,18529,19426,62024,10725,52321,48020,12118,43126,02618,77020,21426,50629,69925,88422,48424,34541,33436,22939,62537,26220,41815,71411,6808,54510,80710,0937,1056,4277,6275,6185,4934,8379,3946,0646,2536,16505,777
       Short-term Debt 
0
0
140
0
150
3,155
160
160
160
165
174
175
180
180
180
180
300
315
9,950
10,040
10,040
10,040
340
315
350
265
245
250
255
260
260
270
270
275
285
290
295
11,263
6,500
7,500
16,621
17,127
25,829
5,725
5,594
21,341
16,047
6,650
7,767
9,007
10,187
11,347
12,538
16,250
17,500
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
6,250
7,500
878
889
889
836
0
0
30,000
2,415
2,444
2,473
2,526
2,560
2,588
2,491
2,299
14,761
4,729
1,652
1,645
1,975
1,931
4,960
5,000
5,0004,9601,9311,9751,6451,6524,72914,7612,2992,4912,5882,5602,5262,4732,4442,41530,000008368898898787,5006,2505,0005,0005,0005,0005,0005,0005,0005,0005,00017,50016,25012,53811,34710,1879,0077,7676,65016,04721,3415,5945,72525,82917,12716,6217,5006,50011,26329529028527527027026026025525024526535031534010,04010,04010,0409,9503153001801801801801751741651601601603,155150014000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
143,215
0
0
0
9,007
0
0
0
16,250
17,500
5,000
5,000
5,000
95,147
5,000
5,000
5,000
5,000
5,000
6,250
7,500
0
0
0
0
0
0
0
0
0
0
0
8,783
8,892
0
9,877
14,761
4,729
0
0
4,728
4,804
4,960
5,000
5,0004,9604,8044,728004,72914,7619,87708,8928,783000000000007,5006,2505,0005,0005,0005,0005,00095,1475,0005,0005,00017,50016,2500009,007000143,215000000000000000000000000000000000000000000000
       Accounts payable 
2,294
0
2,707
2,623
2,071
2,143
2,122
2,444
2,224
3,971
3,135
2,042
4,903
5,791
3,899
5,613
6,848
7,567
5,086
6,974
6,791
9,081
10,535
8,388
9,871
13,152
11,921
8,692
8,640
12,044
8,758
8,056
8,163
11,391
10,729
11,808
16,535
29,200
24,431
20,950
23,664
24,470
26,701
28,336
25,506
32,895
29,282
21,969
21,696
23,048
24,942
21,701
18,067
15,616
15,648
15,286
15,357
18,087
17,421
21,800
16,350
15,775
16,916
19,424
18,443
22,829
16,870
17,968
18,304
19,096
14,008
15,979
17,067
19,630
22,687
24,191
21,570
28,047
29,258
34,688
35,600
40,445
24,807
37,650
35,152
37,751
31,272
34,746
30,265
30,26534,74631,27237,75135,15237,65024,80740,44535,60034,68829,25828,04721,57024,19122,68719,63017,06715,97914,00819,09618,30417,96816,87022,82918,44319,42416,91615,77516,35021,80017,42118,08715,35715,28615,64815,61618,06721,70124,94223,04821,69621,96929,28232,89525,50628,33626,70124,47023,66420,95024,43129,20016,53511,80810,72911,3918,1638,0568,75812,0448,6408,69211,92113,1529,8718,38810,5359,0816,7916,9745,0867,5676,8485,6133,8995,7914,9032,0423,1353,9712,2242,4442,1222,1432,0712,6232,70702,294
       Other Current Liabilities 
2,500
0
3,318
3,490
3,843
3,996
2,410
2,713
3,234
3,491
3,118
4,793
4,514
4,836
4,466
5,248
8,283
12,536
22,226
22,539
19,140
21,280
13,470
13,781
15,663
16,282
14,340
11,272
9,875
13,722
9,413
11,795
13,047
13,841
13,093
14,522
12,364
19,347
16,107
20,923
21,890
19,938
19,078
32,948
31,401
15,992
16,354
27,234
29,547
28,663
24,208
26,653
30,594
34,815
30,161
30,348
29,452
47,573
41,073
31,999
32,389
35,843
22,448
24,113
27,732
42,166
26,885
37,535
29,777
31,715
25,026
28,999
33,189
35,539
28,591
27,811
25,272
42,967
33,606
22,098
31,405
43,380
31,073
39,779
50,214
50,909
42,602
48,028
41,747
41,74748,02842,60250,90950,21439,77931,07343,38031,40522,09833,60642,96725,27227,81128,59135,53933,18928,99925,02631,71529,77737,53526,88542,16627,73224,11322,44835,84332,38931,99941,07347,57329,45230,34830,16134,81530,59426,65324,20828,66329,54727,23416,35415,99231,40132,94819,07819,93821,89020,92316,10719,34712,36414,52213,09313,84113,04711,7959,41313,7229,87511,27214,34016,28215,66313,78113,47021,28019,14022,53922,22612,5368,2835,2484,4664,8364,5144,7933,1183,4913,2342,7132,4103,9963,8433,4903,31802,500
   > Long-term Liabilities 
0
0
19,403
0
19,288
3,100
3,060
3,020
2,980
2,935
2,890
2,845
2,800
2,755
6,210
6,165
30,300
26,905
7,410
7,245
7,160
11,700
11,678
6,930
6,810
6,810
6,745
6,680
6,615
6,550
6,485
6,410
6,345
6,275
6,200
6,125
6,050
142,500
142,104
191,874
202,284
201,317
198,345
196,682
191,105
190,020
192,723
197,823
179,693
167,444
164,015
152,628
141,189
153,940
148,563
138,069
121,927
121,418
118,134
116,926
105,698
105,576
103,193
184,695
170,421
148,321
29,119
54,064
72,774
88,106
88,859
88,366
77,053
64,397
67,716
67,260
64,118
53,938
77,221
76,682
75,562
70,516
8,693
20,360
20,270
20,930
20,347
16,187
21,574
21,57416,18720,34720,93020,27020,3608,69370,51675,56276,68277,22153,93864,11867,26067,71664,39777,05388,36688,85988,10672,77454,06429,119148,321170,421184,695103,193105,576105,698116,926118,134121,418121,927138,069148,563153,940141,189152,628164,015167,444179,693197,823192,723190,020191,105196,682198,345201,317202,284191,874142,104142,5006,0506,1256,2006,2756,3456,4106,4856,5506,6156,6806,7456,8106,8106,93011,67811,7007,1607,2457,41026,90530,3006,1656,2102,7552,8002,8452,8902,9352,9803,0203,0603,10019,288019,40300
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,200
6,125
6,050
142,500
140,625
138,750
136,875
135,000
129,375
135,160
133,910
137,660
136,410
148,910
141,410
128,910
126,410
122,660
113,910
105,160
100,652
110,163
92,519
91,320
90,147
88,973
87,798
86,621
85,444
139,266
126,837
124,407
0
0
14,341
40,000
40,000
40,000
30,000
20,000
0
25,000
25,000
25,000
49,798
49,796
0
49,818
0
0
0
0
0
0
0
000000049,818049,79649,79825,00025,00025,000020,00030,00040,00040,00040,00014,34100124,407126,837139,26685,44486,62187,79888,97390,14791,32092,519110,163100,652105,160113,910122,660126,410128,910141,410148,910136,410137,660133,910135,160129,375135,000136,875138,750140,625142,5006,0506,1256,2000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,927
4,870
5,164
39,198
38,603
9,278
7,268
11,007
10,227
9,507
11,721
10,403
9,236
7,236
16,469
14,904
15,496
19,826
19,563
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000019,56319,82615,49614,90416,4697,2369,23610,40311,7219,50710,22711,0077,2689,27838,60339,1985,1644,8704,9270000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,500
3,500
13,100
9,790
0
0
0
4,625
4,688
0
0
0
0
0
0
0
0
0
0
0
0
0
0
327
1,479
53,124
65,409
66,317
67,769
60,356
56,029
56,497
55,167
47,767
37,137
37,415
36,486
28,849
26,160
26,264
24,665
4,156
4,104
3,986
1,957
1,947
1,938
18,955
17,749
45,429
43,584
23,914
25,630
50,873
50,709
39,552
40,681
40,730
39,113
37,078
36,048
42,260
33,740
24,202
27,423
23,396
22,672
17,382
5,751
0
0
0
0
0
0
0000005,75117,38222,67223,39627,42324,20233,74042,26036,04837,07839,11340,73040,68139,55250,70950,87325,63023,91443,58445,42917,74918,9551,9381,9471,9573,9864,1044,15624,66526,26426,16028,84936,48637,41537,13747,76755,16756,49756,02960,35667,76966,31765,40953,1241,479327000000000000004,6884,6250009,79013,1003,5003,50000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,201
1,166
1,166
1,146
1,146
1,146
1,146
1,119
1,119
1,119
1,119
21,684
23,246
23,750
25,304
26,112
26,030
26,006
15,962
17,173
17,154
17,696
17,834
14,542
14,367
24,586
24,013
24,057
23,817
23,018
22,371
19,955
0
17,994
16,961
16,037
15,115
14,290
0
12,813
0
0
0
0
0
0
0
000000012,813014,29015,11516,03716,96117,994019,95522,37123,01823,81724,05724,01324,58614,36714,54217,83417,69617,15417,17315,96226,00626,03026,11225,30423,75023,24621,6841,1191,1191,1191,1191,1461,1461,1461,1461,1661,1661,201000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
1,488
2,956
3,720
37,232
40,733
41,859
45,237
49,110
52,018
54,288
57,334
123,438
127,003
131,269
331,266
335,958
340,368
345,950
353,550
355,713
359,947
363,537
367,885
372,194
376,029
380,739
386,910
391,349
395,435
399,452
405,574
405,748
409,301
410,845
411,363
523,392
524,509
526,688
527,357
526,830
528,445
529,729
537,689
537,893
540,326
543,570
543,756
545,022
547,123
547,639
550,745
507,027
512,717
523,349
531,750
517,027
517,884
521,220
538,328
542,595
544,889
549,563
554,079
614,815
614,073
613,810
610,475
455,872
455,054
454,343
454,936
439,457
435,950
432,368
429,692
424,489
414,041
407,958
397,655
378,296
427,804
401,226
218,698
205,586
196,582
186,768
185,870
185,870186,768196,582205,586218,698401,226427,804378,296397,655407,958414,041424,489429,692432,368435,950439,457454,936454,343455,054455,872610,475613,810614,073614,815554,079549,563544,889542,595538,328521,220517,884517,027531,750523,349512,717507,027550,745547,639547,123545,022543,756543,570540,326537,893537,689529,729528,445526,830527,357526,688524,509523,392411,363410,845409,301405,748405,574399,452395,435391,349386,910380,739376,029372,194367,885363,537359,947355,713353,550345,950340,368335,958331,266131,269127,003123,43857,33454,28852,01849,11045,23741,85940,73337,2323,7202,9561,48800
   Retained Earnings 
0
0
-10,943
0
-9,346
-8,268
-7,507
-6,471
-5,386
-3,720
-2,427
-772
1,108
3,146
5,044
7,499
-8,907
-5,981
-3,601
-501
4,389
4,908
7,119
10,026
11,938
14,840
16,951
20,080
23,413
27,152
29,040
32,319
36,130
35,269
36,642
38,971
37,203
30,175
29,454
31,423
30,431
29,563
29,137
29,038
34,146
32,651
31,971
33,309
29,047
28,233
27,476
27,114
27,744
-16,015
-14,715
-981
1,906
-11,007
-11,240
-10,992
3,027
5,129
4,660
6,800
7,596
66,469
65,194
62,458
56,749
-100,318
-104,586
-108,854
-112,398
-131,866
-138,838
-147,189
-152,147
-158,413
-171,417
-179,903
-189,388
-210,855
-164,971
-194,019
-381,755
-395,204
-408,002
-418,740
-423,147
-423,147-418,740-408,002-395,204-381,755-194,019-164,971-210,855-189,388-179,903-171,417-158,413-152,147-147,189-138,838-131,866-112,398-108,854-104,586-100,31856,74962,45865,19466,4697,5966,8004,6605,1293,027-10,992-11,240-11,0071,906-981-14,715-16,01527,74427,11427,47628,23329,04733,30931,97132,65134,14629,03829,13729,56330,43131,42329,45430,17537,20338,97136,64235,26936,13032,31929,04027,15223,41320,08016,95114,84011,93810,0267,1194,9084,389-501-3,601-5,981-8,9077,4995,0443,1461,108-772-2,427-3,720-5,386-6,471-7,507-8,268-9,3460-10,94300
   Accumulated Other Comprehensive Income 
0
0
-300
0
-203
-118
-173
-171
-169
-169
-154
-152
-155
-82
-68
-96
-112
-61
-60
-27
41
-36
-279
-861
-1,063
-905
-972
-1,015
-1,223
-1,394
-1,275
-1,402
-1,465
-1,273
-1,349
-1,596
-1,455
-1,274
-1,897
-1,702
-1,741
-1,534
-1,263
-1,522
-1,344
-1,269
-1,243
-1,345
-1,896
-1,568
-1,615
-1,922
-1,790
-791
-1,089
-1,653
-1,697
-1,324
-1,041
-846
-637
-952
-1,044
-1,250
-1,077
-1,352
-1,503
-1,272
-1,264
-1,341
754
1,934
1,946
3,153
3,743
4,562
3,526
1,357
807
-288
-3,850
-4,723
-5,653
-4,708
-2,806
-4,365
-3,267
0
0
00-3,267-4,365-2,806-4,708-5,653-4,723-3,850-2888071,3573,5264,5623,7433,1531,9461,934754-1,341-1,264-1,272-1,503-1,352-1,077-1,250-1,044-952-637-846-1,041-1,324-1,697-1,653-1,089-791-1,790-1,922-1,615-1,568-1,896-1,345-1,243-1,269-1,344-1,522-1,263-1,534-1,741-1,702-1,897-1,274-1,455-1,596-1,349-1,273-1,465-1,402-1,275-1,394-1,223-1,015-972-905-1,063-861-279-3641-27-60-61-112-96-68-82-155-152-154-169-169-171-173-118-2030-30000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
373,756
373,219
375,363
496,375
498,077
498,722
500,421
500,554
502,323
503,964
506,638
508,354
510,704
513,353
518,349
520,101
523,004
524,189
526,532
525,775
530,259
535,558
531,171
532,705
535,511
538,403
541,282
543,762
546,615
549,355
552,902
555,040
555,723
557,965
560,330
561,871
564,225
566,602
570,725
573,507
0
580,330
583,647
586,879
589,984
593,482
0
599,206
0
0
0
0
0
0
0
0000000599,2060593,482589,984586,879583,647580,3300573,507570,725566,602564,225561,871560,330557,965555,723555,040552,902549,355546,615543,762541,282538,403535,511532,705531,171535,558530,259525,775526,532524,189523,004520,101518,349513,353510,704508,354506,638503,964502,323500,554500,421498,722498,077496,375375,363373,219373,7560000000000000000000000000000000000
   Treasury Stock0000000-5,7140-5,714-5,714-5,714-5,714-5,7140-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,714-5,7140-9,944-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,104-2,1040000000000000000000000000000000000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-05-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue303,914
Cost of Revenue-149,216
Gross Profit154,698154,698
 
Operating Income (+$)
Gross Profit154,698
Operating Expense-347,133
Operating Income-192,435-192,435
 
Operating Expense (+$)
Research Development31,512
Selling General Administrative41,164
Selling And Marketing Expenses102,818
Operating Expense347,133175,494
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,614
Other Finance Cost-3,228
Net Interest Income1,614
 
Pretax Income (+$)
Operating Income-192,435
Net Interest Income1,614
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-191,638-193,232
EBIT - interestExpense = -43,618
-191,638
-182,735
Interest Expense1,614
Earnings Before Interest and Taxes (EBIT)-42,004-190,024
Earnings Before Interest and Taxes (EBITDA)-14,292
 
After tax Income (+$)
Income Before Tax-191,638
Tax Provision--7,289
Net Income From Continuing Ops-184,349-184,349
Net Income-184,349
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses496,349
Total Other Income/Expenses Net797-1,614
 

Technical Analysis of Angiodynamics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Angiodynamics. The general trend of Angiodynamics is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Angiodynamics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Angiodynamics Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AngioDynamics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 9.69 < 11.72 < 12.11.

The bearish price targets are: 9.14 > 8.55 > 8.27.

Know someone who trades $ANGO? Share this with them.๐Ÿ‘‡

AngioDynamics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AngioDynamics Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AngioDynamics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AngioDynamics Inc. The current macd is -0.13131318.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Angiodynamics price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Angiodynamics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Angiodynamics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
AngioDynamics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAngioDynamics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AngioDynamics Inc. The current adx is 20.21.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Angiodynamics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
AngioDynamics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AngioDynamics Inc. The current sar is 10.61.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
AngioDynamics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AngioDynamics Inc. The current rsi is 41.72. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
AngioDynamics Inc Daily Relative Strength Index (RSI) ChartAngioDynamics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AngioDynamics Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Angiodynamics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
AngioDynamics Inc Daily Stochastic Oscillator ChartAngioDynamics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AngioDynamics Inc. The current cci is -104.87986326.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
AngioDynamics Inc Daily Commodity Channel Index (CCI) ChartAngioDynamics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AngioDynamics Inc. The current cmo is -25.2296191.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
AngioDynamics Inc Daily Chande Momentum Oscillator (CMO) ChartAngioDynamics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AngioDynamics Inc. The current willr is -84.52683048.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
AngioDynamics Inc Daily Williams %R ChartAngioDynamics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of AngioDynamics Inc.

AngioDynamics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AngioDynamics Inc. The current atr is 0.43884735.

AngioDynamics Inc Daily Average True Range (ATR) ChartAngioDynamics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AngioDynamics Inc. The current obv is -10,862,616.

AngioDynamics Inc Daily On-Balance Volume (OBV) ChartAngioDynamics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AngioDynamics Inc. The current mfi is 26.56.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
AngioDynamics Inc Daily Money Flow Index (MFI) ChartAngioDynamics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AngioDynamics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

AngioDynamics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AngioDynamics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.718
Ma 20Greater thanMa 5010.316
Ma 50Greater thanMa 1009.855
Ma 100Greater thanMa 2009.776
OpenGreater thanClose9.380
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Angiodynamics with someone you think should read this too:
  • Are you bullish or bearish on Angiodynamics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Angiodynamics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AngioDynamics Inc

I send you an email if I find something interesting about AngioDynamics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about AngioDynamics Inc.

Receive notifications about AngioDynamics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.